- Home
- ALLT vs TMCI Comparison
ALLT vs TMCI Comparison
Compare ALLT & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- TMCI
- Stock Information
- Founded
- ALLT 1996
- TMCI 2014
- Country
- ALLT Israel
- TMCI United States
- Employees
- ALLT N/A
- TMCI N/A
- Industry
- ALLT Telecommunications Equipment
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ALLT Telecommunications
- TMCI Health Care
- Exchange
- ALLT Nasdaq
- TMCI Nasdaq
- Market Cap
- ALLT 458.2M
- TMCI 401.8M
- IPO Year
- ALLT 2006
- TMCI 2021
- Fundamental
- Price
- ALLT $9.44
- TMCI $6.59
- Analyst Decision
- ALLT Strong Buy
- TMCI Hold
- Analyst Count
- ALLT 3
- TMCI 5
- Target Price
- ALLT $12.75
- TMCI $8.40
- AVG Volume (30 Days)
- ALLT 340.7K
- TMCI 208.5K
- Earning Date
- ALLT 11-20-2025
- TMCI 11-06-2025
- Dividend Yield
- ALLT N/A
- TMCI N/A
- EPS Growth
- ALLT N/A
- TMCI N/A
- EPS
- ALLT N/A
- TMCI N/A
- Revenue
- ALLT $95,342,000.00
- TMCI $213,751,000.00
- Revenue This Year
- ALLT $10.42
- TMCI $10.63
- Revenue Next Year
- ALLT $13.06
- TMCI $9.43
- P/E Ratio
- ALLT N/A
- TMCI N/A
- Revenue Growth
- ALLT 4.74
- TMCI 7.67
- 52 Week Low
- ALLT $3.35
- TMCI $4.70
- 52 Week High
- ALLT $11.42
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- ALLT 44.13
- TMCI 50.33
- Support Level
- ALLT $9.54
- TMCI $6.23
- Resistance Level
- ALLT $10.69
- TMCI $6.91
- Average True Range (ATR)
- ALLT 0.44
- TMCI 0.28
- MACD
- ALLT -0.10
- TMCI 0.00
- Stochastic Oscillator
- ALLT 17.65
- TMCI 51.96
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.